Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$8.75B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 3 |
Procter & Gamble
PG
|
+$980M |
| 4 |
Apple
AAPL
|
+$894M |
| 5 |
Amazon
AMZN
|
+$815M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$806M |
| 2 |
Palo Alto Networks
PANW
|
+$726M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$654M |
| 4 |
Toronto Dominion Bank
TD
|
+$494M |
| 5 |
Enbridge
ENB
|
+$407M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.1% |
| 2 | Technology | 15.76% |
| 3 | Industrials | 7.8% |
| 4 | Healthcare | 7.3% |
| 5 | Consumer Discretionary | 7.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5651
VanEck Israel ETF
ISRA
$162M
| $80K | ﹤0.01% |
2,325
| – | – |
|
|
SLRN
5652
DELISTED
ACELYRIN
SLRN
| $80K | ﹤0.01% |
10,664
+5,716
| +116% | +$48.8K |
|
|
JBIO
5653
Jade Biosciences
JBIO
$1.57B
| $79K | ﹤0.01% |
99
+59
| +148% | +$30.1K |
|
5654
Clarus
CLAR
$140M
| $79K | ﹤0.01% |
11,479
+6,661
| +138% | +$39.1K |
|
5655
Dimensional US Large Cap Value ETF
DFLV
$7.03B
| $79K | ﹤0.01% |
2,899
+2,639
| +1,015% | +$66.4K |
|
5656
Fennec Pharmaceuticals
FENC
$411M
| $79K | ﹤0.01% |
7,102
+1,236
| +21% | +$10.2K |
|
|
FDIQ
5657
Invesco Bloomberg Financial Data Providers ETF
FDIQ
$48.7M
| $79K | ﹤0.01% |
1,437
-26,102
| -95% | -$1.23M |
|
|
PVBC
5658
DELISTED
Provident Bancorp
PVBC
| $79K | ﹤0.01% |
7,787
+7,606
| +4,202% | +$73.5K |
|
5659
Rigel Pharmaceuticals
RIGL
$795M
| $79K | ﹤0.01% |
5,493
+2,793
| +103% | +$28.6K |
|
5660
Cartesian Therapeutics
RNAC
$267M
| $79K | ﹤0.01% |
3,840
-434
| -10% | -$13K |
|
|
PSTX
5661
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $79K | ﹤0.01% |
23,370
+10,663
| +84% | +$27.5K |
|
|
CALB
5662
DELISTED
California BanCorp Common Stock
CALB
| $79K | ﹤0.01% |
3,189
+3,142
| +6,685% | +$69.8K |
|
5663
Birkenstock
BIRK
$7.24B
| $78K | ﹤0.01% |
+1,596
| New | +$69.1K |
|
5664
TD Synnex
SNX
$20.7B
| $78K | ﹤0.01% |
730
-29,403
| -98% | -$2.89M |
|
|
UBFO
5665
DELISTED
United Security Bancshares
UBFO
| $78K | ﹤0.01% |
+9,300
| New | +$72.7K |
|
|
AGTI
5666
DELISTED
Agiliti Inc
AGTI
| $78K | ﹤0.01% |
9,962
+5,427
| +120% | +$36.8K |
|
5667
Angi Inc
ANGI
$191M
| $77K | ﹤0.01% |
3,063
-1,190
| -28% | -$24.3K |
|
5668
Caledonia Mining Corp
CMCL
$434M
| $77K | ﹤0.01% |
6,244
+2,597
| +71% | +$30.1K |
|
|
DDX
5669
Defined Duration 10 ETF
DDX
$72.8M
| $77K | ﹤0.01% |
3,438
+2,972
| +638% | +$63.4K |
|
5670
KRONOS Worldwide
KRO
$975M
| $77K | ﹤0.01% |
7,644
+3,628
| +90% | +$29.5K |
|
5671
LXP Industrial Trust 6.5% Series C Preferred Stock
LXP.PRC
$94.9M
| – | – |
0
| – | – |
|
5672
908 Devices
MASS
$414M
| $77K | ﹤0.01% |
6,916
+2,195
| +46% | +$15K |
|
|
TGAN
5673
DELISTED
Transphorm, Inc. Common Stock
TGAN
| $77K | ﹤0.01% |
20,964
+17,441
| +495% | +$47.8K |
|
5674
CorMedix
CRMD
$592M
| $76K | ﹤0.01% |
20,179
+11,490
| +132% | +$39.5K |
|
|
ITOS
5675
DELISTED
iTeos Therapeutics
ITOS
| $76K | ﹤0.01% |
6,949
+2,788
| +67% | +$27.6K |
|
Similar funds
Royal Bank of Canada's Q4 2023 Portfolio in Review
As of Q4 2023, Royal Bank of Canada held 7,942 positions worth $428B, up 16% from $369B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Royal Bank of Canada deployed $17.2B of net new capital in Q4 2023, opening 466 new positions and adding to 4,113 existing holdings. Its largest new stake was Franklin Income Focus ETF: 394,628 shares worth $10.1M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was PepsiCo, an estimated $806M trimmed.
- Royal Bank of Canada's largest Q4 2023 buy was Franklin Income Focus ETF: 394,628 shares worth $10.1M.
- Royal Bank of Canada added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $8.75B increase.
- Royal Bank of Canada's biggest Q4 2023 reduction was PepsiCo, cutting an estimated $806M.
- Royal Bank of Canada fully exited Activision Blizzard in Q4 2023, selling an estimated $69.3M.
- Royal Bank of Canada's ten largest holdings make up 20% of its $428B portfolio in Q4 2023.
- Royal Bank of Canada opened 466 new positions and closed 401 in Q4 2023.
- Royal Bank of Canada's portfolio value rose 16% quarter-over-quarter to $428B.
Based on Royal Bank of Canada's 13F filing for Q4 2023, filed 14 Feb 2024.